http://hyper.ahajournals.org/content/early/2013/04/22/HYP.0b013e318293645f.full.pdf
While the study isn't about TM specifically, the fact that TM is given a seat at the table as a "clinical treatment" for high blood pressure in this journal is HUGE. >From the thomas-reuters journal ranking site: Impact Factor/Ranking: The journal ranks #1 among all hypertension journals and #4 among 67 journals in the Peripheral Vascular Disease category (Journal Citation Reports® 2011, Thomson Reuters, 2012). L
